BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32741225)

  • 1. Chemotherapy combinations for B-cell lymphoma and chemo-free approach in elderly patients: an update on best practice.
    Santambrogio E; Novo M; Rota-Scalabrini D; Vitolo U
    Expert Rev Hematol; 2020 Aug; 13(8):851-869. PubMed ID: 32741225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mature B-NHL in children, adolescents and young adults: current therapeutic approach and emerging treatment strategies.
    Egan G; Goldman S; Alexander S
    Br J Haematol; 2019 Jun; 185(6):1071-1085. PubMed ID: 30613948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative intent therapy for DLBCL in the elderly.
    Tucci A; Masina L; Luminari S
    Leuk Lymphoma; 2024 May; 65(5):560-569. PubMed ID: 38206922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108A.
    Kinoshita T; Watanabe T; Itoh K; Yoshimura K; Tobinai K; Ogura M; Yamaguchi M; Kurosawa M; Imaizumi Y; Ota S; Kaba H; Mukai K; Nakamura S; Ohshima K; Hotta T; Tsukasaki K; Nagai H; Shimoyama M
    J Clin Exp Hematop; 2021; 61(1):35-41. PubMed ID: 33731548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior outcomes with paediatric protocols in adolescents and young adults with aggressive B-cell non-Hodgkin lymphoma.
    Gupta S; Alexander S; Pole JD; Sutradhar R; Crump M; Nagamuthu C; Baxter NN; Nathan PC
    Br J Haematol; 2022 Feb; 196(3):743-752. PubMed ID: 34599525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma.
    Camus V; Tilly H
    Expert Rev Hematol; 2017 Dec; 10(12):1047-1055. PubMed ID: 27791447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of polatuzumab vedotin for the treatment of patients with diffuse large B-cell lymphoma.
    Walji M; Assouline S
    Expert Rev Hematol; 2020 Sep; 13(9):933-942. PubMed ID: 32700586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lenalidomide for the treatment of B-cell lymphoma.
    Garciaz S; Coso D; Schiano de Colella JM; Bouabdallah R
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1103-16. PubMed ID: 27414850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse Large B-cell Lymphoma in the elderly: standard treatment and new perspectives.
    Chiappella A; Castellino A; Nicolosi M; Santambrogio E; Vitolo U
    Expert Rev Hematol; 2017 Apr; 10(4):289-297. PubMed ID: 28290728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma of the Eyelid - An International Multicenter Retrospective Study.
    Svendsen FH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    Am J Ophthalmol; 2017 May; 177():58-68. PubMed ID: 28209503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma.
    Chiappella A; Santambrogio E; Castellino A; Nicolosi M; Vitolo U
    Expert Rev Hematol; 2017 Aug; 10(8):697-705. PubMed ID: 28665232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-chemotherapy Options for Newly Diagnosed Mantle Cell Lymphoma.
    Takiar R; Phillips T
    Curr Treat Options Oncol; 2021 Sep; 22(11):98. PubMed ID: 34524546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.
    Ong DM; Ashby M; Grigg A; Gard G; Ng ZY; Huang HE; Chong YS; Cheah CY; Devitt B; Chong G; Loh Z; Mo A; Hawkes EA
    Br J Haematol; 2019 Oct; 187(1):73-81. PubMed ID: 31206608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of comprehensive geriatric assessment in predicting early mortality among elder patients with B-cell lymphoma receiving immunochemotherapy.
    Chou WC; Chang H; Wang PN; Kuo MC; Wu JH; Lin TL; Su YJ; Kao HW; Ou CW; Hung CY; Hsueh SW; Hung YS
    Eur J Haematol; 2020 Oct; 105(4):399-407. PubMed ID: 32472712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.
    Kikuchi M; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kako S; Kanda J; Nishida J; Sekiguchi N; Noto S; Kida M; Hangaishi A; Usuki K; Kanda Y
    J Chemother; 2015 Feb; 27(2):99-105. PubMed ID: 25314911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for consolidation to improve progression-free survival in patients with non-Hodgkin's lymphoma: a review of the evidence.
    Morschhauser F; Dreyling M; Rohatiner A; Hagemeister F; Bischof Delaloye A
    Oncologist; 2009; 14 Suppl 2():17-29. PubMed ID: 19819921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
    Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS
    Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fading star of obinutuzumab-chlorambucil regimen in patients with comorbidities with chronic lymphocytic leukemia - are we ready for chemo-free immunotherapy approach?
    Milunović V; Mišura Jakobac K; Mandac Rogulj I; Martinović M; Radić-Krišto D; Ostojić Kolonić S
    Expert Rev Hematol; 2020 Jul; 13(7):771-779. PubMed ID: 32579408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.